Document:

Exhibit 10.3

 

OPTION TO ACQUIRE
SHARES

OF COMMON STOCK OF
NATIONAL HEALTH PARTNERS, INC.

 

WHEREAS, National Health
Partners, Inc., an Indiana corporation (the “Company”) wishes to grant
this option to Patricia S. Bathurst (the “Holder”).

 

NOW, THEREFORE, in
consideration of the foregoing, the agreement set forth below and other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, and intending to be legally bound hereby, the parties hereby
agree as follows:

 

1.                                       Grant of Option. 
The Company hereby grants to the Holder on this 31st day of March,
2010 (the “Grant Date”) an option (this “Option”) to purchase 500,000 shares (“Shares”)
of the Company’s common stock, $.001 par value per share (“Common Stock”), on
the terms and subject to the conditions set forth herein.

 

2.                                       Term of Option. 
This option shall have a maximum term of ten (10) years measured
from the Grant Date (the “Expiration Date”) and shall accordingly expire at
5:00 p.m. eastern standard time on the Expiration Date.

 

3.                                       Right to Exercise. 
This Option may be exercised in whole or in part commencing on the Grant
Date.

 

4.                                      Exercise Price.  The exercise price per Share (“Exercise Price”)
at which this Option may be exercised shall be four and one-half cents ($0.045)
per Share.

 

5.                                       Method of Exercise.

 

(a)                                  This Option shall be exercised by
execution and delivery of the Notice of Exercise attached hereto as Appendix
A (“Notice of Exercise”) or any other written notice approved for such
purpose by the Company that shall state the election of the Holder to exercise
this Option, the number of Shares in respect of which this Option is being
exercised, and such other representations and agreements as to the holder’s
investment intent with respect to such Shares as may be required by the
Company.  The Notice of Exercise shall be
accompanied by payment of the Exercise Price. 
This Option shall be deemed to be exercised upon receipt by the Company
of the Notice of Exercise accompanied by payment of the Exercise Price.

 

(b)                                 No Shares shall be issued pursuant to the
exercise of this Option unless such issuance and such exercise shall comply
with all relevant provisions of applicable law, including the requirements of
any stock exchange upon which the Shares may then be listed.  Assuming such compliance, for income tax
purposes the Shares shall be considered transferred to the Holder on the date
on which this Option is exercised with respect to such Shares.

 

(c)                                  This Option may not be exercised for a
fractional Share or scrip representing a fractional Share.  In lieu of any fractional Share to which the
Holder would

 

 

otherwise be entitled,
the Company shall make a cash payment equal to the Exercise Price multiplied by
such fraction.

 

(d)                                 In no event may this Option be exercised
after the Expiration Date.

 

6.                                       Methods of Payment. 
Shares of Common Stock purchased upon the exercise of this Option may be
paid for as follows:

 

(a)                                  in cash or by check,
payable to the order of the Company;

 

(b)                                 if the shares of
Common Stock underlying the Option are registered under the Securities Act of
1933, as amended (the “Securities Act”), by: (i) delivery by the Holder to
the Company of an irrevocable and unconditional undertaking by a creditworthy
broker to deliver promptly to the Company sufficient funds to pay the exercise
price and any required tax withholding, or (ii) delivery by the Holder to
the Company of a copy of irrevocable and unconditional instructions to a
creditworthy broker to deliver promptly to the Company the exercise price and
any required tax withholding;

 

(c)                                  if the shares of
Common Stock underlying the Option are registered under the Securities Act, by
delivery of such shares of Common Stock owned by the Holder valued at their
Fair Market Value (as defined below), provided: (i) such method of payment
is then permitted under applicable law, (ii) such shares of Common Stock
have been owned by the Holder at least six months prior to the date of such
delivery, and (iii) such shares of Common Stock are not subject to any
repurchase, forfeiture, unfulfilled vesting or other similar requirements or
restrictions;

 

(d)                                 by reducing the number
of shares of Common Stock otherwise issuable under this Option to the Holder
upon the exercise of this Option by a number of shares of Common Stock having a
Fair Market Value equal to such aggregated exercise price; provided, however,
that such method of payment is then permitted under applicable law;

 

(e)                                  to the extent
permitted by applicable law and by the board of directors of the Company (the “Board”),
in its sole discretion, by: (i) delivery of a promissory note of the
Holder to the Company on terms determined by the Board, or (ii) payment of
such other lawful consideration as the Board may determine; or

 

(f)                                    by any combination of
the above permitted forms of payment.

 

For the purpose of this
Agreement, “Fair Market Value” shall mean:

 

(i)                              If the Common Stock is admitted to
quotation on the National Association of Securities Dealers Automated Quotation
System (“NASDAQ”), the Fair Market Value on any given date shall be the average
of the highest bid and lowest ask prices of the Common Stock as reported for
such date or, if no bid and ask prices were reported for such date, for the
last day preceding such date for which such prices were reported;

 

(ii)                           If the Common Stock is admitted to
trading on a United States national securities exchange or the NASDAQ National
Market System, the Fair Market Value on

 

2

 

any given date
shall be the closing price reported for the Common Stock on such exchange
or system for such date or, if no sales were reported for such date, for the
last day preceding such date for which a sale was reported;

 

(iii)                        If the Common
Stock is traded in the over-the-counter market and not on NASDAQ, the NASDAQ
National Market System or any United States national securities exchange, the
Fair Market Value on any given date shall be the average of the mean between
the last bid and ask prices per share as reported by the National Quotation
Bureau, Inc. or an equivalent generally accepted reporting service for
such date or, or if not so reported, the average of the closing bid and ask
prices of the Common Stock for such date as furnished to the Company by any
member of the National Association of Securities Dealers, Inc. selected by
the Company for that purpose; or

 

(iv)                              If the Fair Market Value of
the Common Stock cannot be determined on the basis previously set forth in this
definition on the date that the Fair Market Value is to be determined, the
Board shall in good faith determine the Fair Market Value of the Common Stock
on such date.

 

The delivery of certificates representing the
shares of Common Stock to be purchased pursuant to the exercise of this Option
will be contingent upon receipt from the Holder (or a purchaser acting in his
stead in accordance with the provisions of this Option) by the Company of the
full purchase price for the Shares and the fulfillment of any other
requirements contained in this Option or imposed by applicable law.

 

7.                                       Rights of Stockholder. 
The Holder shall not have any stockholder rights with respect to any
Shares until such Holder shall have exercised this Option, paid the Exercise
Price and become a holder of record of the purchased Shares.

 

8.                                       Adjustment of Exercise Price and Number
of Shares.  The number and kind of securities purchasable
upon exercise of this Option and the Exercise Price shall be subject to
adjustment from time to time as follows:

 

(a)                                  Subdivisions, Combinations
and Other Issuances.  If the
Company shall at any time prior to the expiration of this Option subdivide its
Common Stock, by split-up or otherwise, or combine its Common Stock, or issue
additional shares of its Common Stock or any preferred stock as a dividend with
respect to any shares of its Common Stock, then the number of Shares issuable
on the exercise of this Option shall forthwith be proportionately increased in
the case of a subdivision or stock dividend, or proportionately decreased in
the case of a combination.  Appropriate
adjustments shall also be made to the Exercise Price, but the aggregate
purchase price payable for the total number of Shares purchasable under this
Option (as adjusted) shall remain the same. 
Any adjustment under this Section 8(a) shall become effective
at the close of business on the date the subdivision or combination becomes
effective, or as of the record date of such dividend, or in the event that no
record date is fixed, upon the making of such dividend.

 

(b)                                 Reclassification,
Reorganization and Consolidation.  In the case of any reclassification, capital
reorganization or change in the Common Stock of the Company (other

 

3

 

than as a result of a subdivision,
combination or stock dividend provided for in Section 8(a) above or
as a result of any “Fundamental Transaction” described in Section 8(c) below),
then, as a condition of such reclassification, reorganization or change, lawful
provision shall be made, and duly executed documents evidencing the same from
the Company or its successor shall be delivered to the Holder, so that the
Holder shall have the right at any time prior to the expiration of this Option
to purchase, at a total price equal to that payable upon the exercise of this
Option, the kind and amount of shares of stock and other securities and
property receivable in connection with such reclassification, reorganization or
change by a holder of the same number of shares of Common Stock as were
purchasable by the Holder immediately prior to such reclassification,
reorganization or change.  In any such
case, appropriate provisions shall be made with respect to the rights and
interest of the Holder so that the provisions hereof shall thereafter be
applicable with respect to any shares of stock or other securities and property
deliverable upon exercise hereof, and appropriate adjustments shall be made to
the Exercise Price payable hereunder, provided the aggregate purchase price
shall remain the same.

 

(c)                                  Corporate Reorganizations, Consolidations
or Mergers.  In the event of: (i) any reorganization,
consolidation or merger of the Company with or into another entity (other than
a merger in which the Company is the successor entity that does not result in
any capital reclassification, reorganization or consolidation, or other
change, in the Common Stock of the Company, or a consolidation or merger
between the Company and a wholly-owned subsidiary of the Company), (ii) any sale, lease, transfer or
conveyance to another entity of all or substantially all of the stock, property
and assets of the Company (other than a transfer to a wholly-owned subsidiary
of the Company), or (iii) a liquidation or dissolution of the Company (the
events in subsections (i), (ii) and (iii) collectively, a “Fundamental
Transaction”), then, as a condition of such Fundamental
Transaction, lawful provision shall be made by the Company and the successor
entity in connection
with such Fundamental Transaction for the assumption of this Option by the
successor entity or for the substitution of new like-kind options by the
successor entity as a result of such Fundamental Transaction, with appropriate
adjustment as to the number and kind of shares issuable upon exercise of the
Option, and, if appropriate, the per share exercise price, so as to enable the
Holder after such Fundamental Transaction to purchase the kind and amount of
shares of stock and other securities and property (including cash) receivable
upon such consolidation, merger, sale or conveyance by a holder of the number of
shares of Common Stock that would have been received upon the exercise or
exchange of this Option immediately prior to such Fundamental Transaction.

 

(d)                                 Notice of
Adjustment.  When any
adjustment is required to be made in the number or kind of shares purchasable
upon exercise of this Option or in the Exercise Price, the Company shall
promptly notify the Holder of such event and of the number of shares of Common
Stock or other securities or property thereafter purchasable upon exercise of
this Option.

 

(e)                              No Impairment.  The Company and the Holder will not, by any
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company or the
Holder, respectively, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 8 and in the taking of
all such action as may be necessary or appropriate in order to protect the
rights or the Company and the Holder against impairment.

 

4

 

9.                                       Termination of Option.

 

(a)                                  Termination by Death.  If Holder’s employment by, or other
relationship with, the Company terminates by reason of death, this Option may
thereafter be exercised, in whole or in part to the extent exercisable on the
date of such termination of employment, by the legal representative or legatee
of the Holder until the earlier of the date that is one year after the date of
such termination of employment or the Expiration Date.

 

(b)                             Termination by Reason
of Disability or Retirement.

 

(i)                                    Disability.                                          If Holder’s employment
by, or other relationship with, the Company terminates by reason of disability
as set forth in Section 22(e)(3) of the Internal Revenue Code (“Disability”),
this Option may thereafter be exercised, in whole or in part to the extent
exercisable on the date of such termination of employment, until the earlier of
the date that is one year after the date of such termination of employment or
the Expiration Date.

 

(ii)                                 Retirement.                                    If Holder retires in
good standing from active employment or service with the Company in accordance
with the retirement policies of the Company then in effect (“Retirement”), this
Option may thereafter be exercised, in whole or in part to the extent
exercisable on the date of such termination of employment, until the earlier of
the date that is 90 days after the date of such termination of employment or
the Expiration Date

 

(iii)                              Disability and
Retirement Determination.  The Board
shall have sole authority and discretion to determine whether the Holder’s
employment or services has been terminated by reason of Disability or
Retirement.

 

(c)                                  Termination for Cause.  If Holder’s employment by, or other
relationship with, the Company terminates for “Cause,” this Option shall
immediately terminate and be of no further force and effect; provided, however,
that the Board may, in its sole discretion, provide that this Option may be
exercised until the earlier of the date that is 90 days after the date of such
termination of employment or the Expiration Date.  Termination for “Cause” shall have the
meaning ascribed to such term in the Employment Agreement dated May 13,
2005 by and between the Company and Holder (the “Employment Agreement”).

 

(d)                                 Termination Without
Cause or Termination for Good Reason. 
If Holder’s employment by, or other relationship with, the Company
terminates for any reason other than death, Disability, Retirement or for
Cause, or if Holder’s employment by, or other relationship with, the Company is
terminated by Holder for “Good Reason,” this Option shall vest in full
immediately.  Termination for “Good
Reason” shall have the meaning ascribed to such term in the Employment
Agreement.

 

(e)                                  Transfer and Leave of Absence. 
For purposes of this Option, the following events shall not be deemed a
termination of employment: (i) a transfer of employment between any of the
Company, a parent, a subsidiary or any other affiliate of the Company, and (ii) an
approved leave of absence for military service or sickness, or for any other
purpose approved by the Board, if the Holder’s right to re-employment is
guaranteed by a statute, by

 

5

 

contract or under the
policy pursuant to which the leave of absence was granted, or if the Board
otherwise so provides in writing.

 

10.                                 Investment Intent.

 

(a)                                  The Holder of this Option, by acceptance
hereof, acknowledges that this Option and the Shares to be issued upon exercise
hereof (collectively, the “Securities”) are being acquired for the Holder’s own
account for investment purposes only and not with a view to, or with any
present intention of, distributing or reselling any of such Securities.  The Holder acknowledges and agrees that the
Securities have not been registered under the Securities Act or under any state
securities laws, and that the Securities may not be, directly or indirectly,
sold, transferred, offered for sale, pledged, hypothecated or otherwise
disposed of without registration under the Securities Act and registration or qualification
under applicable state securities laws, except pursuant to an available
exemption from such registration.  The
Holder also acknowledges and agrees that neither the Securities Exchange
Commission (“SEC”) nor any securities commission or other governmental
authority has: (i) approved the transfer of the Securities or passed upon
or endorsed the merits of the transfer of the Securities; or (ii) confirmed
the accuracy of, determined the adequacy of, or reviewed this Option.  The Holder has such knowledge, sophistication
and experience in financial, tax and business matters in general, and
investments in securities in particular, that it is capable of evaluating the
merits and risks of this investment in the Securities, and the Holder has made
such investigations in connection herewith as it deemed necessary or desirable
so as to make an informed investment decision without relying upon the Company
for legal or tax advice related to this investment.

 

(b)                                 The certificates evidencing any Shares
issued upon the exercise of this Option shall have endorsed thereon (except to
the extent that the restrictions described in any such legend are no longer
applicable) the following legend, appropriate notations thereof will be made in
the Company’s stock transfer books, and stop transfer instructions reflecting
these restrictions on transfer will be placed with the transfer agent of the
Shares.

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES
LAWS.  THESE SECURITIES MAY NOT BE
SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO REGISTRATION
UNDER THE SECURITIES ACT AND REGISTRATION OR QUALIFICATION UNDER APPLICABLE
STATE SECURITIES LAWS, OR PURSUANT TO AN AVAILABLE EXEMPTION THEREFROM.  NO TRANSFER OF THE SECURITIES REPRESENTED
HEREBY MAY BE MADE IN THE ABSENCE OF SUCH REGISTRATION OR QUALIFICATION
UNLESS THERE SHALL HAVE BEEN DELIVERED TO THE ISSUER A WRITTEN OPINION OF
UNITED STATES COUNSEL OF RECOGNIZED STANDING, IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER, TO THE EFFECT THAT SUCH TRANSFER MAY BE MADE
WITHOUT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND
REGISTRATION 

 

6

 

OR QUALIFICATION
UNDER APPLICABLE STATE SECURITIES LAWS.

 

11.                                 Covenants of the Company. 
The Company covenants and agrees that the Shares have been duly
authorized and, when issued and paid for in accordance with the terms of this
Agreement, will be validly issued, fully paid and non-assessable shares of
Common Stock with no personal liability resulting solely from the ownership of
such shares and will be free and clear of all liens, charges, restrictions,
claims and encumbrances imposed by or through the Company.

 

12.                                 Replacement of Option. 
On receipt of evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of this Option and, in the case of loss,
theft or destruction, on delivery of an indemnity agreement reasonably satisfactory
in form and substance to the Company or, in the case of mutilation, on
surrender and cancellation of this Option, the Company at its expense shall
execute and deliver, in lieu of this Option, a new Option of like tenor and
amount.

 

13.                                Notices.  All notices hereunder shall be sufficiently
given for all purposes hereunder if in writing and delivered personally, sent
by documented overnight delivery service or, to the extent receipt is
confirmed, telecopy, telefax or other electronic transmission service to the
appropriate address or number as set forth below:

 

If to the Company:

 

National Health Partners, Inc.

120 Gibraltar Road

Suite 107

Horsham, PA 19044

Attention:  Chief Financial
Officer

 

If to the Holder:

 

To the address specified
for Holder in the Company’s records.

 

14.                                 Amendment and Waiver. 
This Option may not be amended, modified or supplemented except by an
instrument or instruments in writing signed by the party against whom
enforcement of any such amendment, modification or supplement is sought.  The parties hereto entitled to the benefits
of a term or provision may waive compliance with any obligation, covenant,
agreement or condition contained herein. 
Any agreement on the part of a party to any such waiver shall be valid
only if set forth in an instrument or instruments in writing signed by the
party against whom enforcement of any such waiver is sought.   No failure or delay on the part of any party
hereto in the exercise of any right hereunder shall impair such right or be
construed to be a waiver of, or acquiescence in, any breach of any
representation, warranty, covenant or
agreement contained herein.

 

15.                                 Headings; Definitions. 
The section headings contained in this Option are inserted for
convenience of reference only and will not affect the meaning or interpretation
of this Option.  All references to
sections contained herein mean sections of this Option unless otherwise
stated.  

 

7

 

All capitalized terms
defined herein are equally applicable to both the singular and plural forms of
such terms.

 

16.                                 Successors and Assigns. 
This Option shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and assigns, provided, however,
that no party hereto may assign its rights or delegate its obligations under
this Option without the express prior written consent of the other party
hereto.  Nothing in this Option is
intended to confer upon any person not a party hereto (and their successors and
assigns) any rights, remedies, obligations or liabilities under or by reason of
this Option.

 

17.                                 Severability. 
If any provision of this Option or the application thereof to any person
or circumstance is held to be invalid or unenforceable to any extent, the
remainder of this Option shall remain in full force and effect and shall be
reformed to render this Option valid and enforceable while reflecting to the
greatest extent permissible the intent of the parties.

 

18.                                 Governing Law. 
This Agreement shall be governed by and construed in accordance with the
laws of the Commonwealth of Pennsylvania, without regard to the laws that might
otherwise govern under applicable principles of conflicts of laws thereof.

 

19.                                 Counterparts. 
This Agreement may be executed and delivered by facsimile in two or more
counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same agreement.

 

[Remainder of page intentionally
left blank]

 

8

 

IN WITNESS WHEREOF, the Company and Holder have caused
this Option to be executed as of the date set forth above in Section 1 of
this Option.

 

 

	
   

  	
   

  	
  NATIONAL HEALTH
  PARTNERS, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: 

  	
  /s/ David M.
  Daniels

  
	
   

  	
   

  	
   

  	
  David M. Daniels

  
	
   

  	
   

  	
   

  	
  Chief Executive
  Officer

  
	
   

  	
   

  	
   

  
	
  AGREED AND
  ACCEPTED:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  By: 

  	
  /s/ Patricia S.
  Bathurst

  	
   

  	
   

  
	
   

  	
  Patricia S. Bathurst

  	
   

  	
   

  

 

9

 

APPENDIX A

 

NOTICE OF EXERCISE

 

To:              National Health
Partners, Inc.

120 Gibraltar Road

Suite 107

Horsham, PA 19044

Attention: Chief Financial Officer

 

(1)                                  The undersigned hereby elects to purchase
                          
shares of Common Stock of the Company pursuant to the terms of the attached
Option, and tenders herewith payment of the purchase price for such shares in
full in accordance with the terms of the Option in the following manner (please
check one or more of the following choices):

 

o                                    in cash or by check;

 

o                                    an irrevocable and unconditional
undertaking by a creditworthy broker to deliver sufficient funds to pay the
exercise price and any required tax withholding;

 

o                                    a copy of irrevocable and unconditional
instructions to a creditworthy broker to deliver the exercise price and any
required tax withholding;

 

o                                    a promissory note;

 

o                                    a reduction of the number of shares of
Common Stock otherwise issuable under the Option by a number of shares of
Common Stock having a Fair Market Value equal to such aggregated exercise
price; or

 

o                                    the following consideration:
                                                                        .

 

(2)                                  In exercising the Option, the undersigned
hereby confirms and acknowledges that the shares of Common Stock to be issued
upon conversion thereof are being acquired solely for the account of the
undersigned for investment purposes only (unless such shares are subject to
resale pursuant to an effective registration statement or an exemption from
registration under applicable federal and state securities laws), and that the
undersigned will not offer, sell or otherwise dispose of any such shares of
Common Stock except under circumstances that will not result in a violation of
the Securities Act or any state securities laws.

 

(3)                                  Terms not otherwise defined in this
Notice of Exercise shall have the meanings ascribed to such terms in the
attached Option.

 

(4)                                  Please issue a certificate or
certificates representing said shares of Common Stock in the name of the
undersigned.

 

	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  (Date)

  	
   

  	
  (Signature)Exhibit 10.4

 

SECURITIES AGREEMENT

 

THIS SECURITIES
AGREEMENT (this “Agreement”), dated March 31, 2010, is entered into by and
between National Health Partners, Inc.,
an Indiana corporation (the “Company”), and Alex Soufflas (“Employee”).

 

R E C I T A L S:

 

WHEREAS, the
Company owes Employee $14,765 of salary compensation earned by Employee during
the period commencing January 1, 2010 and ending January 31, 2010, and payable
to Employee as of January 31, 2010 (the “Deferred Compensation”); and

 

WHEREAS, Employee
wishes to terminate the aforementioned Deferred Compensation in exchange for
the right to receive shares of common stock, $0.001 par value per share (“Common
Stock”), of the Company on the terms and conditions set forth herein.

 

NOW, THEREFORE, in
consideration of the foregoing premises and representations, warranties,
covenants and agreements contained herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
and intending to be legally bound hereby, the parties hereto hereby agree as
follows:

 

1.                                       Termination of Deferred Compensation. 
Employee hereby irrevocably terminates the Deferred Compensation.

 

2.                                       Consideration. 
In consideration of Employee terminating the Deferred Compensation, the
Company hereby agrees to issue to Employee 328,112 shares (the “Shares”) of
Common Stock.

 

3.                                       Representations and Warranties of Employee.  Employee
represents and warrants to the Company as follows:

 

(a)                                  This Agreement has been duly and validly
authorized, executed and delivered by Employee and, assuming it has been duly
and validly executed and delivered by the Company, constitutes a legal, valid
and binding obligation of Employee, in accordance with its terms.

 

(b)                                 Neither the execution and delivery of
this Agreement by Employee nor the performance by Employee of his or her
obligations hereunder will: (i) violate any statute, law, ordinance, rule or
regulation, applicable to Employee or any of the properties or assets of Employee;
or (ii) violate, breach, be in conflict with or constitute a default (or an
event which, with notice or lapse of time or both, would constitute a default)
under, or permit the termination of any provision of, or result in the
termination of, the acceleration of the maturity of, or the acceleration of the
performance of any obligation of Employee under, or result in the creation or
imposition of any lien upon any properties, assets or business of Employee
under, any material contract or any order, judgment or decree to which Employee
is a party or by which her or she or any of his or her assets or properties is
bound or encumbered except for such violations, 

 

 

breaches, conflicts, defaults or other occurrences which, individually
or in the aggregate, would not have a material adverse effect on his or her
obligation to perform his or her covenants under this Agreement.

 

(c)                                  Accredited Investor.  Employee
is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D under the Securities Act of 1933, as amended (the “Securities Act”).

 

(d)                                 Investment Intent. 
The Securities are being acquired for the Employee’s own account for
investment purposes only, not as a nominee or agent and not with a view to the
resale or distribution of any part thereof, and Employee has no present
intention of selling, granting any participation in or otherwise distributing
the same.  By executing this Agreement, Employee
further represents that Employee does not have any contract, undertaking,
agreement or arrangement with any person to sell, transfer or grant
participation to such person or third person with respect to any of the
Securities.

 

(e)                                  Restrictions on Transfer.  Employee
understands that the Securities are “restricted securities” as such term is
defined in Rule 144 under the Securities Act and have not been registered under
the Securities Act or registered or qualified under any state securities law,
and may not be, directly or indirectly, sold, transferred, offered for sale,
pledged, hypothecated or otherwise disposed of without registration under the
Securities Act and registration or qualification under applicable state
securities laws or the availability of an exemption therefrom.

 

4.                                       Representations and Warranties of the
Company.  The Company represents and warrants to Employee
as follows:

 

(a)                                  Organization and Qualification. 
The Company is duly organized, validly existing and in good standing
under the laws of its jurisdiction of organization, with the corporate power
and authority to own and operate its business as presently conducted, except
where the failure to be or have any of the foregoing would not have a material
adverse effect on the Company.  The
Company is duly qualified as a foreign corporation or other entity to do
business and is in good standing in each jurisdiction where the character of
its properties owned or held under lease or the nature of their activities
makes such qualification necessary, except for such failures to be so qualified
or in good standing as would not have a material adverse effect on the Company.

 

(b)                                 Authority; Validity and Effect of
Agreement.

 

(i)                                     The Company has the requisite corporate
power and authority to execute and deliver this Agreement and perform its
obligations under this Agreement.  The
execution and delivery of this Agreement by the Company, the performance by the
Company of its obligations hereunder and all other necessary corporate action
on the part of the Company have been duly authorized by its board of directors,
and no other corporate proceedings on the part of the Company is necessary to
authorize this Agreement.  This Agreement
has been duly and validly executed and delivered by the Company and, assuming
that it has been duly authorized, executed and delivered by Employee,
constitutes a legal, valid and binding obligation of the Company, in accordance
with its terms, subject to the effects of bankruptcy, insolvency, 

 

2

 

fraudulent conveyance, reorganization, moratorium and other similar
laws relating to or affecting creditors’ rights generally, general equitable
principles (whether considered in a proceeding in equity or at law) and an
implied covenant of good faith and fair dealing.

 

(ii)                                  The Shares have been duly authorized and,
when issued and paid for in accordance with this Agreement, will be validly
issued, fully paid and non-assessable shares of Common Stock with no personal
liability resulting solely from the ownership of such shares and will be free
and clear of all liens, charges, restrictions, claims and encumbrances imposed
by or through the Company.

 

(c)                                  No Conflict; Required Filings and
Consents.  Neither the execution and delivery of this
Agreement by the Company nor the performance by the Company of its obligations
hereunder will: (i) conflict with the Company’s Articles of Incorporation or
Bylaws; (ii) violate any statute, law, ordinance, rule or regulation,
applicable to the Company or any of the properties or assets of the Company; or
(iii) violate, breach, be in conflict with or constitute a default (or an event
which, with notice or lapse of time or both, would constitute a default) under,
or permit the termination of any provision of, or result in the termination of,
the acceleration of the maturity of, or the acceleration of the performance of
any obligation of the Company, or result in the creation or imposition of any
lien upon any properties, assets or business of the Company under, any material
contract or any order, judgment or decree to which the Company is a party or by
which it or any of its assets or properties is bound or encumbered except, in
the case of clauses (ii) and (iii), for such violations, breaches, conflicts,
defaults or other occurrences which, individually or in the aggregate, would
not have a material adverse effect on its obligation to perform its covenants
under this Agreement.

 

5.                                       Entire Agreement. 
This Agreement contains the entire agreement between the parties and
supersedes all prior agreements and understandings, both written and oral,
between the parties with respect to the subject matter hereto, and no party
shall be liable or bound to any other party in any manner by any warranties,
representations, guarantees or covenants except as specifically set forth in
this Agreement.  Nothing in this
Agreement, express or implied, is intended to confer upon any party other than
the parties hereto or their respective successors and assigns any rights,
remedies, obligations or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.

 

6.                                       Amendment and Modification. 
This Agreement may not be amended, modified or supplemented except by an
instrument or instruments in writing signed by the party against whom
enforcement of any such amendment, modification or supplement is sought.

 

7.                                       Successors and Assigns. 
This Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and assigns, provided, however,
that no party hereto may assign its rights or delegate its obligations under
this Agreement without the express prior written consent of the other party
hereto.  Nothing in this Agreement is
intended to confer upon any person not a party hereto (and their successors and
assigns) any rights, remedies, obligations or liabilities under or by reason of
this Agreement.

 

8.                                       Headings; Definitions. 
The Section headings contained in this Agreement are inserted for
convenience of reference only and will not affect the meaning or interpretation
of 

 

3

 

this Agreement.  All references to Sections contained herein
mean Sections of this Agreement unless otherwise stated.  All capitalized terms defined herein are
equally applicable to both the singular and plural forms of such terms.

 

9.                                       Severability. 
If any provision of this Agreement or the application thereof to any
person or circumstance is held to be invalid or unenforceable to any extent,
the remainder of this Agreement shall remain in full force and effect and shall
be reformed to render the Agreement valid and enforceable while reflecting to
the greatest extent permissible the intent of the parties hereto.

 

10.                                 Notices.  All notices
hereunder shall be sufficiently given for all purposes hereunder if in writing
and delivered personally, sent by documented overnight delivery service or, to
the extent receipt is confirmed, telecopy, telefax or other electronic
transmission service to the appropriate address or number as set forth below:

 

If to the Company:

 

National Health Partners, Inc.

120 Gibraltar Road

Suite 107

Horsham, PA 19044

Attention: 
Chief Financial Officer

 

If to Employee:

 

To the address set forth
on the signature page hereof.

 

11.                                 Governing Law. 
This Agreement shall be governed by and construed in accordance with the
laws of the Commonwealth of Pennsylvania, without regard to the laws that might
otherwise govern under applicable principles of conflicts of laws thereof,
except to the extent that the Indiana Business Corporation Law shall apply to
the internal corporate governance of the Company.

 

12.                                 Counterparts. 
This Agreement may be executed and delivered by facsimile in two or more
counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same agreement.

 

[Remainder of page intentionally
left blank]

 

4

 

IN WITNESS
WHEREOF, intending to be legally bound, the parties hereto have fully executed
this Agreement as of the later of the dates set forth below.

 

	
   

  	
  NATIONAL HEALTH
  PARTNERS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ David M. Daniels

  
	
   

  	
   

  	
  David M. Daniels

  
	
   

  	
   

  	
  President and Chief
  Executive Officer

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  EMPLOYEE

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  /s/ Alex Soufflas

  
	
   

  	
  Alex Soufflas

  

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]